EN
HI
Bal Pharma Chart
Bal Pharma Share Key Metrics
Volume
14301.00
Market Cap
139.13 CR
LTQ@LTP
31@87.39
ATP
86.56
Var Margin
25 %
Circuit Range
68.72-103.08
Delivery %
61.67 %
Value
12.38 L
ASM/GSM
No
Market Lot
1
Summary
Bal Pharma share price is ₹87.39 as of 3 Jun, 2026. The stock Bal Pharma intraday movement has stayed between ₹84.46 and ₹88.40, while on a 52-week basis,Bal Pharma price 52 week high is ₹111.18 & its 52 week low is ₹60.00.
In terms of trading activity, Bal Pharma has recorded a volume of 14301 shares, The Bal Pharma has a market cap of ₹15920872 CR. The stock’s Average Traded Price (ATP) stands at ₹86.56, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 31 @ ₹87.39.
Bal Pharma operates within a circuit range of ₹68.72 – ₹103.08, with a Value of ₹12.38 L. The Delivery Percentage for the day is 61.67%. Additionally, Bal Pharma currently falls under the No framework, and trades with a market lot size of 1.
Bal Pharma Fundamentals
View MoreP/E Ratio
21.82
P/B Ratio
1.67
Div. Yield
1.39
Sector P/E
69.94
Sector P/B
2.97
Sec. Div. Yield
0.55
Bal Pharma Resistance and Support
Pivot 87.75
Resistance
First Resistance
90.45
Second Resistance
95
Third Resistance
97.7
Support
First Support
83.2
Second Support
80.5
Third Support
75.95
Bal Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-27 | Audited Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
| 2025-05-29 | Audited Results & Dividend |
| 2025-02-13 | Quarterly Results & Fund Raising |
Bal Pharma News
Bal Pharma Ltd - 524824 - Board Meeting Outcome for Outcome Of The Board Meeting
Bal Pharma's Board approved Q4 FY26 and FY26 consolidated financial results. For Q4 FY26, cons. revenue was ₹84.08 Cr (up 2.68% YoY) and net profit ₹3.60 Cr (down 33.5% YoY). The Board also recommended a dividend of ₹1.20 per equity share for FY26 and approved a preferential issue of 1 million warrants to promoters.
May 27 2026 18:30:14
Bal Pharma Ltd - 524824 - Announcement under Regulation 30 (LODR)-Meeting Updates
Bal Pharma's Board of Directors is scheduled to meet on May 27, 2026. The agenda includes considering a proposal for fund-raising via preferential issue warrants to promoters, in addition to previously announced items.
May 22 2026 17:37:18
Read More
Bal Pharma Management
| Name | Position |
|---|---|
| Shailesh Siroya | Managing Director |
| Himesh Virupakshaya | Whole Time Director |
Bal Pharma FAQs
The Buying Price of Bal Pharma share is 87.39 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bal Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bal Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bal Pharma shares is 21.82. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bal Pharma shares is 1.67. Useful to assess the stock's value relative to its book value.
To assess Bal Pharma’s valuation compare Sector P/E, P/B which are 69.94 & 2.97 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bal Pharma is 139.13 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bal Pharma share price is 111.18 & 60.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bal Pharma belongs to the Healthcare sector.
